Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Treatment of collagenase-induced osteoarthritis with a viral vector encoding TSG-6 results in ectopic bone formation.

Broeren MGA, Di Ceglie I, Bennink MB, van Lent PLEM, van den Berg WB, Koenders MI, Blaney Davidson EN, van der Kraan PM, van de Loo FAJ.

PeerJ. 2018 May 30;6:e4771. doi: 10.7717/peerj.4771. eCollection 2018.

2.

Protective Role of the MER Tyrosine Kinase via Efferocytosis in Rheumatoid Arthritis Models.

Waterborg CEJ, Beermann S, Broeren MGA, Bennink MB, Koenders MI, van Lent PLEM, van den Berg WB, van der Kraan PM, van de Loo FAJ.

Front Immunol. 2018 Apr 13;9:742. doi: 10.3389/fimmu.2018.00742. eCollection 2018.

3.

Functional Tissue Analysis Reveals Successful Cryopreservation of Human Osteoarthritic Synovium.

Broeren MG, de Vries M, Bennink MB, van Lent PL, van der Kraan PM, Koenders MI, Thurlings RM, van de Loo FA.

PLoS One. 2016 Nov 21;11(11):e0167076. doi: 10.1371/journal.pone.0167076. eCollection 2016.

4.

Suppression of the inflammatory response by disease-inducible interleukin-10 gene therapy in a three-dimensional micromass model of the human synovial membrane.

Broeren MG, de Vries M, Bennink MB, Arntz OJ, van Lent PL, van der Kraan PM, van den Berg WB, van den Hoogen FH, Koenders MI, van de Loo FA.

Arthritis Res Ther. 2016 Aug 12;18:186. doi: 10.1186/s13075-016-1083-1.

5.

Tetraspanin CD37 protects against the development of B cell lymphoma.

de Winde CM, Veenbergen S, Young KH, Xu-Monette ZY, Wang XX, Xia Y, Jabbar KJ, van den Brand M, van der Schaaf A, Elfrink S, van Houdt IS, Gijbels MJ, van de Loo FA, Bennink MB, Hebeda KM, Groenen PJ, van Krieken JH, Figdor CG, van Spriel AB.

J Clin Invest. 2016 Feb;126(2):653-66. doi: 10.1172/JCI81041. Epub 2016 Jan 19.

6.

Disease-Regulated Gene Therapy with Anti-Inflammatory Interleukin-10 Under the Control of the CXCL10 Promoter for the Treatment of Rheumatoid Arthritis.

Broeren MG, de Vries M, Bennink MB, Arntz OJ, Blom AB, Koenders MI, van Lent PL, van der Kraan PM, van den Berg WB, van de Loo FA.

Hum Gene Ther. 2016 Mar;27(3):244-54. doi: 10.1089/hum.2015.127. Epub 2016 Feb 16.

PMID:
26711533
7.

Oral administration of bovine milk derived extracellular vesicles attenuates arthritis in two mouse models.

Arntz OJ, Pieters BC, Oliveira MC, Broeren MG, Bennink MB, de Vries M, van Lent PL, Koenders MI, van den Berg WB, van der Kraan PM, van de Loo FA.

Mol Nutr Food Res. 2015 Sep;59(9):1701-12. doi: 10.1002/mnfr.201500222. Epub 2015 Jul 1.

PMID:
26047123
8.

The in-vivo use of superparamagnetic iron oxide nanoparticles to detect inflammation elicits a cytokine response but does not aggravate experimental arthritis.

Vermeij EA, Koenders MI, Bennink MB, Crowe LA, Maurizi L, Vallée JP, Hofmann H, van den Berg WB, van Lent PL, van de Loo FA.

PLoS One. 2015 May 8;10(5):e0126687. doi: 10.1371/journal.pone.0126687. eCollection 2015.

9.

Commercial cow milk contains physically stable extracellular vesicles expressing immunoregulatory TGF-β.

Pieters BC, Arntz OJ, Bennink MB, Broeren MG, van Caam AP, Koenders MI, van Lent PL, van den Berg WB, de Vries M, van der Kraan PM, van de Loo FA.

PLoS One. 2015 Mar 30;10(3):e0121123. doi: 10.1371/journal.pone.0121123. eCollection 2015.

10.

TGF-β is a potent inducer of Nerve Growth Factor in articular cartilage via the ALK5-Smad2/3 pathway. Potential role in OA related pain?

Blaney Davidson EN, van Caam AP, Vitters EL, Bennink MB, Thijssen E, van den Berg WB, Koenders MI, van Lent PL, van de Loo FA, van der Kraan PM.

Osteoarthritis Cartilage. 2015 Mar;23(3):478-86. doi: 10.1016/j.joca.2014.12.005. Epub 2014 Dec 18.

11.

Disease-regulated local IL-10 gene therapy diminishes synovitis and cartilage proteoglycan depletion in experimental arthritis.

Vermeij EA, Broeren MG, Bennink MB, Arntz OJ, Gjertsson I, van Lent PL, van den Berg WB, Koenders MI, van de Loo FA.

Ann Rheum Dis. 2015 Nov;74(11):2084-91. doi: 10.1136/annrheumdis-2014-205223. Epub 2014 Jul 15.

PMID:
25028707
12.

In vivo molecular imaging of cathepsin and matrix metalloproteinase activity discriminates between arthritic and osteoarthritic processes in mice.

Vermeij EA, Koenders MI, Blom AB, Arntz OJ, Bennink MB, van den Berg WB, van Lent PL, van de Loo FA.

Mol Imaging. 2014;13:1-10.

PMID:
24881106
13.

Inducible chondrocyte-specific overexpression of BMP2 in young mice results in severe aggravation of osteophyte formation in experimental OA without altering cartilage damage.

Blaney Davidson EN, Vitters EL, Bennink MB, van Lent PL, van Caam AP, Blom AB, van den Berg WB, van de Loo FA, van der Kraan PM.

Ann Rheum Dis. 2015 Jun;74(6):1257-64. doi: 10.1136/annrheumdis-2013-204528. Epub 2014 Jan 21.

PMID:
24448347
14.

Intravenous delivery of HIV-based lentiviral vectors preferentially transduces F4/80+ and Ly-6C+ cells in spleen, important target cells in autoimmune arthritis.

van den Brand BT, Vermeij EA, Waterborg CE, Arntz OJ, Kracht M, Bennink MB, van den Berg WB, van de Loo FA.

PLoS One. 2013;8(2):e55356. doi: 10.1371/journal.pone.0055356. Epub 2013 Feb 4.

15.

Toll-like receptor 4 in bone marrow-derived cells as well as tissue-resident cells participate in aggravating autoimmune destructive arthritis.

van den Brand BT, Abdollahi-Roodsaz S, Bennink MB, Bussink J, Arntz OJ, van den Berg WB, van de Loo FA.

Ann Rheum Dis. 2013 Aug;72(8):1407-15. doi: 10.1136/annrheumdis-2012-202467. Epub 2013 Jan 3.

PMID:
23291389
16.

Therapeutic efficacy of Tyro3, Axl, and Mer tyrosine kinase agonists in collagen-induced arthritis.

van den Brand BT, Abdollahi-Roodsaz S, Vermeij EA, Bennink MB, Arntz OJ, Rothlin CV, van den Berg WB, van de Loo FA.

Arthritis Rheum. 2013 Mar;65(3):671-80. doi: 10.1002/art.37786.

17.

Enhanced suppressor of cytokine signaling 3 in arthritic cartilage dysregulates human chondrocyte function.

van de Loo FA, Veenbergen S, van den Brand B, Bennink MB, Blaney-Davidson E, Arntz OJ, van Beuningen HM, van der Kraan PM, van den Berg WB.

Arthritis Rheum. 2012 Oct;64(10):3313-23. doi: 10.1002/art.34529.

18.

A pivotal role for antigen-presenting cells overexpressing SOCS3 in controlling invariant NKT cell responses during collagen-induced arthritis.

Veenbergen S, Bennink MB, Affandi AJ, Bessis N, Biton J, Arntz OJ, van den Berg WB, van de Loo FA.

Ann Rheum Dis. 2011 Dec;70(12):2167-75. doi: 10.1136/ard.2011.154815. Epub 2011 Aug 27.

PMID:
21873688
19.

Abnormal actomyosin assembly in proliferating and differentiating myoblasts upon expression of a cytosolic DMPK isoform.

Mulders SA, van Horssen R, Gerrits L, Bennink MB, Pluk H, de Boer-van Huizen RT, Croes HJ, Wijers M, van de Loo FA, Fransen J, Wieringa B, Wansink DG.

Biochim Biophys Acta. 2011 May;1813(5):867-77. doi: 10.1016/j.bbamcr.2011.01.024. Epub 2011 Feb 2.

20.

A crucial role for tumor necrosis factor receptor 1 in synovial lining cells and the reticuloendothelial system in mediating experimental arthritis.

Arntz OJ, Geurts J, Veenbergen S, Bennink MB, van den Brand BT, Abdollahi-Roodsaz S, van den Berg WB, van de Loo FA.

Arthritis Res Ther. 2010;12(2):R61. doi: 10.1186/ar2974. Epub 2010 Apr 6.

21.

A tail-anchored myotonic dystrophy protein kinase isoform induces perinuclear clustering of mitochondria, autophagy, and apoptosis.

Oude Ophuis RJ, Wijers M, Bennink MB, van de Loo FA, Fransen JA, Wieringa B, Wansink DG.

PLoS One. 2009 Nov 25;4(11):e8024. doi: 10.1371/journal.pone.0008024.

22.

Computational design and application of endogenous promoters for transcriptionally targeted gene therapy for rheumatoid arthritis.

Geurts J, Joosten LA, Takahashi N, Arntz OJ, Glück A, Bennink MB, van den Berg WB, van de Loo FA.

Mol Ther. 2009 Nov;17(11):1877-87. doi: 10.1038/mt.2009.182. Epub 2009 Aug 18.

23.

The natural soluble form of IL-18 receptor beta exacerbates collagen-induced arthritis via modulation of T-cell immune responses.

Veenbergen S, Smeets RL, Bennink MB, Arntz OJ, Joosten LA, van den Berg WB, van de Loo FA.

Ann Rheum Dis. 2010 Jan;69(1):276-83. doi: 10.1136/ard.2008.100867.

PMID:
19188194
24.

Splenic suppressor of cytokine signaling 3 transgene expression affects T cell responses and prevents development of collagen-induced arthritis.

Veenbergen S, Bennink MB, de Hooge AS, Arntz OJ, Smeets RL, van den Berg WB, van de Loo FA.

Arthritis Rheum. 2008 Dec;58(12):3742-52. doi: 10.1002/art.24072.

25.

Application of a disease-regulated promoter is a safer mode of local IL-4 gene therapy for arthritis.

Geurts J, Arntz OJ, Bennink MB, Joosten LA, van den Berg WB, van de Loo FA.

Gene Ther. 2007 Dec;14(23):1632-8. Epub 2007 Sep 13.

PMID:
17851546
26.

A novel role for suppressor of cytokine signaling 3 in cartilage destruction via induction of chondrocyte desensitization toward insulin-like growth factor.

Smeets RL, Veenbergen S, Arntz OJ, Bennink MB, Joosten LA, van den Berg WB, van de Loo FA.

Arthritis Rheum. 2006 May;54(5):1518-28.

27.

Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.

Smeets RL, Joosten LA, Arntz OJ, Bennink MB, Takahashi N, Carlsen H, Martin MU, van den Berg WB, van de Loo FA.

Arthritis Rheum. 2005 Jul;52(7):2202-11.

28.

Divergent mitochondrial and endoplasmic reticulum association of DMPK splice isoforms depends on unique sequence arrangements in tail anchors.

van Herpen RE, Oude Ophuis RJ, Wijers M, Bennink MB, van de Loo FA, Fransen J, Wieringa B, Wansink DG.

Mol Cell Biol. 2005 Feb;25(4):1402-14.

29.

Male IL-6 gene knock out mice developed more advanced osteoarthritis upon aging.

de Hooge AS, van de Loo FA, Bennink MB, Arntz OJ, de Hooge P, van den Berg WB.

Osteoarthritis Cartilage. 2005 Jan;13(1):66-73.

30.

Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice.

de Hooge AS, van de Loo FA, Koenders MI, Bennink MB, Arntz OJ, Kolbe T, van den Berg WB.

Arthritis Rheum. 2004 Jun;50(6):2014-23.

32.

An inflammation-inducible adenoviral expression system for local treatment of the arthritic joint.

van de Loo FA, de Hooge AS, Smeets RL, Bakker AC, Bennink MB, Arntz OJ, Joosten LA, van Beuningen HM, van der Kraan PK, Varley AW, van den Berg WB.

Gene Ther. 2004 Apr;11(7):581-90.

PMID:
14973543
33.

Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritis.

Smeets RL, van de Loo FA, Joosten LA, Arntz OJ, Bennink MB, Loesberg WA, Dmitriev IP, Curiel DT, Martin MU, van den Berg WB.

Arthritis Rheum. 2003 Oct;48(10):2949-58.

34.

Deficiency of NADPH oxidase components p47phox and gp91phox caused granulomatous synovitis and increased connective tissue destruction in experimental arthritis models.

van de Loo FA, Bennink MB, Arntz OJ, Smeets RL, Lubberts E, Joosten LA, van Lent PL, Coenen-de Roo CJ, Cuzzocrea S, Segal BH, Holland SM, van den Berg WB.

Am J Pathol. 2003 Oct;163(4):1525-37.

35.

Growth plate damage, a feature of juvenile idiopathic arthritis, can be induced by adenoviral gene transfer of oncostatin M: a comparative study in gene-deficient mice.

de Hooge AS, van de Loo FA, Bennink MB, Arntz OJ, Fiselier TJ, Franssen MJ, Joosten LA, Van Lent PL, Richards CD, van den Berg WB.

Arthritis Rheum. 2003 Jun;48(6):1750-61.

36.

Adenoviral delivery of IL-18 binding protein C ameliorates collagen-induced arthritis in mice.

Smeets RL, van de Loo FA, Arntz OJ, Bennink MB, Joosten LA, van den Berg WB.

Gene Ther. 2003 Jun;10(12):1004-11.

PMID:
12776157
37.
38.

A tropism-modified adenoviral vector increased the effectiveness of gene therapy for arthritis.

Bakker AC, Van de Loo FA, Joosten LA, Bennink MB, Arntz OJ, Dmitriev IP, Kashentsera EA, Curiel DT, van den Berg WB.

Gene Ther. 2001 Dec;8(23):1785-93.

Supplemental Content

Loading ...
Support Center